Alzheimer’s dementia is generally more prevalent in women than in men, and doctors believe that one reason why is the sudden ...

Estrogen-only hormone therapy later in life was associated with a lower risk of developing the neurodegenerative condition.

The new study is drawing fresh attention to a treatment whose use has steadily declined in the U.S. over the past two decades ...

A study found that people who used estrogen-only menopausal hormonal therapy were less likely to show increased Alzheimer’s ...

Use of hormone therapy later in life was associated with a lower risk of developing dementia, according to a study published in Neurology.

In a retrospective study, people taking estrogen-only hormone therapy for menopause were less likely to see signs of dementia ...

Women who used estrogen-only hormone therapy later in life were less likely to develop dementia and showed fewer signs of Alzheimer’s disease in their brains, according to a large study of more than ...

Women who used estrogen-only menopausal hormonal therapy later in life had lower risks for neuropathologic and clinical outcomes related to Alzheimer’s disease, according to data published in ...

The study looked at data from 163 million American women.

Menopause marks a pivotal transition, but “the change” doesn’t just affect fertility. It also affects women’s cardiovascular ...

The woman said she spent years seeking medical help for a range of symptoms to no avail, but all that changed after her ...

Anti-Müllerian hormone (AMH) appears to predict the benefit of chemotherapy plus endocrine therapy (CET) versus ET alone in ...